Pacira Biosciences, Inc.: how funds voted at the meeting of 9 Jun 2026
- Ticker
- PCRX
- Meeting
- Season
- year to 30 June 2026
- Filers reporting
- 381
- Ballot items
- 6
381 filers on Form N-PX reported votes at the Pacira Biosciences, Inc. meeting of 9 Jun 2026. The records fall into 6 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.
If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.
The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .
The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.
The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.
The page gives records. It gives no investment advice and no advice on how to vote.
Season on this page: year to 30 June 2026. Filings read through . How the figures are made
The ballot
Item 1: Director elections
6 nominees. 64.2% of the reported votes are for. 43 filers withheld from or voted against at least one nominee.
1,731 vote records from 128 filers. 6 of the 124 filers that marked the item voted against management. 4 filers gave no management mark.
- Positions of 42 fund families
- For 28
- Abstain or withhold 3
- Split or no vote 11
- Against management 2
Item 2: Director elections (nominees put forward by security holders)
6 nominees. 3.5% of the reported votes are for. 101 filers withheld from or voted against at least one nominee.
1,362 vote records from 103 filers. 2 of the 99 filers that marked the item voted against management. 4 filers gave no management mark.
- Positions of 37 fund families
- For 1
- Abstain or withhold 28
- Split or no vote 8
- Against management 1
Item 3: Advisory vote on executive pay (say-on-pay)
1,081 vote records from 381 filers. 173 of the 352 filers that marked the item voted against management. 29 filers gave no management mark.
- Positions of 48 fund families
- For 14
- Against 21
- Split or no vote 13
- Against management 21
Item 4: Audit-related items (auditor ratification)
519 vote records from 128 filers. 1 of the 124 filers that marked the item voted against management. 4 filers gave no management mark.
- Positions of 42 fund families
- For 34
- Split or no vote 8
Item 5: CAPITAL STRUCTURE: management items
The company's items in this category are shown together, because filers word and number them differently.
25 vote records from 13 filers. 1 of the 13 filers that marked the item voted against management.
- Positions of 3 fund families
- For 3
Item 6: COMPENSATION: management items
The company's items in this category are shown together, because filers word and number them differently.
1,027 vote records from 129 filers. 10 of the 125 filers that marked the item voted against management. 4 filers gave no management mark.
- Positions of 42 fund families
- For 13
- Against 2
- Split or no vote 27
- Against management 2
Positions of the fund families
A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.
KeyForAgainstAbstain or withholdSplit or no voteAgainst management
| Fund family | 3. Say-on-pay | 4. Auditor |
|---|---|---|
| AllianceBernstein | Split | No report |
| Allspring | Split | Split |
| American Century | For | For |
| BlackRock and iShares | For | For |
| BNY Mellon | For | For |
| Brighthouse Funds | Split | Split |
| Charles Schwab | Split | Split |
| Columbia Threadneedle | Against, against management | For |
| Dimensional | Against, against management | For |
| DWS | Against, against management | For |
| Equitable | For | For |
| Federated Hermes | Split | No report |
| Fidelity | For | For |
| First Trust | Against, against management | For |
| Franklin Templeton | Against, against management | For |
| Global X | Split | Split |
| Goldman Sachs | For | For |
| Guggenheim and Rydex | Against, against management | For |
| Harbor Funds | For | For |
| Hartford Funds | Split | Split |
| Invesco | Against, against management | For |
| J.P. Morgan | Against, against management | For |
| Jackson National funds | For | For |
| John Hancock and Manulife | Against, against management | For |
| Lincoln Financial | Split | Split |
| Lord Abbett | Split | No report |
| MassMutual | Split | No report |
| MFS | Against, against management | For |
| Morgan Stanley, Eaton Vance and Calvert | For | For |
| Nationwide | Against, against management | For |
| Natixis and Loomis Sayles | Against, against management | No report |
| Neuberger Berman | Split | No report |
| Northern Trust and FlexShares | Against, against management | For |
| Nuveen and TIAA | For | For |
| Pacific Life funds | For | For |
| PGIM and Prudential | Against, against management | For |
| Principal | Against, against management | For |
| ProShares and ProFunds | Against, against management | For |
| Russell Investments | Split | Split |
| SEI | Split | Split |
| State Street and SPDR | For | For |
| T. Rowe Price | Against, against management | For |
| Thrivent | Against, against management | For |
| Vanguard | For | For |
| Victory Capital | Against, against management | For |
| Virtus | Against, against management | For |
| Voya | Against, against management | For |
| WisdomTree | For | For |
Questions
- How many filers reported votes at the Pacira Biosciences, Inc. meeting?
- 381 Form N-PX filers reported votes at the meeting of 9 Jun 2026. On say-on-pay, 173 of 352 filers that marked the item voted against management (49.1%).
- Is this the result of the meeting?
- No. The page counts the filers that report on Form N-PX, and the shares they reported. Pacira Biosciences, Inc. reports the result of a vote on Form 8-K.
- Why does the page show counts only for director elections?
- A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Pacira Biosciences, Inc. with a meeting date within three days of 9 Jun 2026. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .